Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine-Folic Acid Tablets in Hypertension with Hyperhomocysteinemia
NCT01956786Phase 3Unknown
- Sponsor
- Shenzhen Ausa Pharmaceutical
- Start
- Sep 2013
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine, folic acid in hypertension (HTN), hyperhomocysteinemia, sponsored by Shenzhen Ausa Pharmaceutical. Status: unknown.
02
Drugs
amlodipinefolic acid
03
Conditions
hypertension (HTN)hyperhomocysteinemia
Beyond the preview
Go deeper on NCT01956786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01956786.